The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF

• Publish Date: 2017-09-22

Research Abstract:

The amplification of human epidermal growth factor receptor 2 (HER2) gene in breast cancer identifies patients eligible for Trastuzumab therapy. immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) are the only FDA approved techniques for evaluating HER2 status. However, Interobserver variability is still a dilemma

Publishers: